Zydus Cadila has launched tablet Tenglyn, the generic version of oral anti-diabetic drug Gliptins, in India. Tenglyn, priced at ₹7 a tablet, is almost a sixth of the price at which Gliptins was initially launched in India. The company had earlier ... Hindu Business Line, 1 week ago
Zydus launches 'Tenglyn', the most affordable gliptin for diabetics in India - Equity Bulls, 5 days ago
Zydus launches Tenglyn tablets in Indian market - Economic Times, 1 week ago
NEW DELHI: Zydus Cadila has received US health regulator's nod to initiate phase II clinical trials of Sarolitazar, its new drug for treating high fat levels in body due to diabetes, obesity, and sedentary habits. "United States Food and Drug ...Economic Times, 1 week ago Zydus gets FDA nod for clinical trials of Sarolitazar Financial Chronicle, 1 week ago
Its total income has increased from Rs 2,122.61 crore for the quarter ended September 30 in the 2014-15 fiscal to Rs 2,483.19 crore in the second quarter of the current fiscal. Representational Image Pharma firm Cadila Healthcare Ltd ...DNA India, 1 month ago
Details Category: Small Molecules Published on Wednesday, 18 November 2015 09:24 Hits: 44 AHMEDABAD, India I November 18, 2015 I Zydus today announced that USFDA has endorsed company's plan to initiate a Phase 2 clinical trial of Saroglitazar ...PipelineReview, 1 week ago
LONDON, Nov. 26, 2015 /PRNewswire/ This report analyzes the worldwide markets for Biopharmaceuticals in US$ Million by the following Segments: Recombinant Protein, Monoclonal Antibodies (mAbs), Insulin, and Vaccines. The report provides separate ...Pharmacy Choice, 1 day ago
Opportunities in PCSK9 Inhibitors, CETP Inhibitors, MTTP Inhibitors, ApoB Inhibitors and PPAR Agonists What can be expected from the cholesterol-lowering drugs market? Which areas are going to grow at the fastest rates? This visiongain report ...Fat Pitch Financials, 4 days ago
More from: BioSpace, Town Hall...and 22 other sources
Biosimilar market is projected to be worth USD 32 billion worldwide by 2025 According to 'Global Biosimilars Market, 2015-2025'
Dublin, Nov. 12, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/b2mt8g/global ) has announced the addition of the "Global Biosimilars Market, 2015 - 2025" report to their offering. Overall, with the ...Franklin Credit Management Corporation, 2 weeks ago Contract Manufacturing in Pharmaceutical Industry, 2015-2025 - North America and Europe are the predominant regions where majority of the production facilities of CMOs are located Tutorial Finder, 2 weeks ago Global Biosimilars Market Report, 2015-2025 - The biosimilar market is projected to be worth USD 32 billion worldwide by 2025 Ulitzer, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!